167 F. Supp. 3d 1029
N.D. Cal.2016Background
- Magnachip, a semiconductor maker, restated 2011–2013 financials after admitting improper revenue recognition; restatement revealed large overstatements and caused a steep stock price decline in February 2015.
- Avenue Capital was a majority Magnachip shareholder entering the class period, appointed multiple board and audit-committee designees, and sold substantial shares (including a large sale in August 2013).
- Plaintiffs consolidated two class actions and filed a Third Amended Complaint alleging Exchange Act and Securities Act violations against Magnachip, officers, directors (including Avenue designees), underwriters, and Avenue Capital.
- Parties settled claims against all defendants except Avenue Capital; the court therefore resolved only claims remaining against Avenue Capital: Exchange Act §§ 20(a) and 20A, and Securities Act §§ 12(a)(2) and 15.
- The court accepted judicially-noticeable SEC filings and public reports cited in the complaint and applied the PSLRA/Rule 9(b) heightened pleading standards.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether plaintiffs pleaded a primary §10(b)/Rule 10b-5 violation (material misstatement, scienter, loss causation, making) | Magnachip’s pervasive, large revenue misstatements, management admissions, resignations, SOX certifications, audit-committee membership, and motive support scienter; filings and signatures show defendants “made” statements; stock drops show loss causation | Defendants say allegations insufficient for scienter, loss causation, and many individual defendants were outside directors who did not "make" statements | Court: Primary 10(b) violation pleaded. Collectively allegations give a strong inference of scienter; loss causation adequately alleged; signing/form filings suffice to plead “making.” |
| Whether Avenue is liable as a controlling person under §20(a) | Avenue exercised control by majority ownership (initially), appointing directors/audit-committee designees who signed filings and continued to wield influence after share sales | Avenue says it became a minority holder and mere ownership or board designees aren’t enough to show control without specific operative facts | Court: §20(a) claim survives. Allegations that Avenue retained control through appointees and statements of continued influence are sufficient at pleading stage. |
| Whether §20A insider-trading claim against Avenue survives (contemporaneous trading and possession/use of MNPI) | Avenue’s employee-designees (Elkins, Klein) had scienter and confidential knowledge; their knowledge can be imputed to Avenue; Lead Plaintiff traded contemporaneously with Avenue’s sale | Avenue argues plaintiff must show the insider actually used the information to trade (not mere possession) and knowledge should not be imputed | Court: §20A claim survives. Court adopts a ‘‘possession’’ (not actual-use) standard for §20A; knowledge of Avenue employees plausibly imputed at pleading stage. |
| Whether Securities Act claims (§§11, 12(a)(2)) and related §15 control-person claim against Avenue are viable (timeliness and statutory standing/tracing) | Plaintiffs contend actionable misstatements weren’t sufficiently disclosed until August 12, 2014, so claims (filed April 2015 by OPPRS) are timely; plaintiffs allege their shares are traceable to the 2/13 offering | Defendants argue March 11, 2014 restatement announcement, contemporaneous market coverage, and Lead Plaintiff’s March 12, 2014 complaint put a diligent plaintiff on notice, so §11/12 claims are time-barred; plaintiffs also fail to trace shares to the offering | Court: §§11 and 12(a)(2) claims dismissed with prejudice. Court finds claims time-barred and, alternatively, that plaintiffs failed to plead the required tracing/statutory standing; §15 control-person claim dismissed accordingly. |
Key Cases Cited
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (2007) (PSLRA "strong inference" scienter standard; holistic analysis)
- In re Daou Sys., Inc., 411 F.3d 1006 (9th Cir. 2005) (elements of Rule 10b-5 claim; loss causation discussion)
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (pleading standards; conclusory allegations insufficient)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (plausibility pleading standard)
- Janus Capital Grp. v. First Deriv. Traders, 564 U.S. 135 (2011) (definition of who "makes" a statement under Rule 10b-5)
- In re Century Aluminum Co. Sec. Litig., 729 F.3d 1104 (9th Cir. 2013) (Securities Act tracing requirement for statutory standing)